FPMI Restructures CardioPET License With Massachusetts General Hospital
27 sept. 2018 09h00 HE
|
FluoroPharma Medical, Inc.
MONTCLAIR, NJ, Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- FluoroPharma Medical Inc. (OTCQB: FPMI) announced today that it has reached an agreement with The General Hospital Corporation,...
FluoroPharma Announces Closing of Stock Buyback Transaction
10 janv. 2018 17h06 HE
|
FluoroPharma Medical, Inc.
Montclair, NJ , Jan. 10, 2018 (GLOBE NEWSWIRE) -- FluoroPharma Medical Inc. (OTCQB: FPMI) today announced it completed the buyback of convertible preferred and common shares held by Platinum Long...
FluoroPharma Announces the Promotion of Tamara Rhein to CFO
22 août 2012 13h22 HE
|
FluoroPharma Medical, Inc.
MONTCLAIR, N.J., Aug. 22, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
FluoroPharma Announces Milestone for BFPET
26 juil. 2012 13h23 HE
|
FluoroPharma Medical, Inc.
MONTCLAIR, N.J., July 26, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
FluoroPharma CEO Provides Shareholders With a "State of the Union" Communication
18 juin 2012 09h00 HE
|
FluoroPharma Medical, Inc.
MONTCLAIR, N.J., June 18, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough molecular imaging products that utilize positron...
Thijs Spoor Appointed Chairman of the Board of FluoroPharma Medical, Inc.
15 juin 2012 16h12 HE
|
FluoroPharma Medical, Inc.
MONTCLAIR, N.J., June 15, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
LifeTech Capital Initiates Coverage of FluoroPharma Medical, Inc.
31 mai 2012 14h49 HE
|
FluoroPharma Medical, Inc.
BOSTON, May 31, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough diagnostic imaging products that utilize positron emission...
FluoroPharma is Granted Patent Rights for BFPET in Australia, Expanding Global Patent Position
19 mars 2012 10h12 HE
|
FluoroPharma Medical, Inc.
BOSTON, March 19, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI) today announces that BFPET, its imaging agent for measuring cardiovascular blood flow, has been granted patent rights...
FluoroPharma Medical Announces Phase II Study for CardioPET
01 mars 2012 10h15 HE
|
FluoroPharma Medical, Inc.
BOSTON, March 1, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough diagnostic imaging products that utilize positron emission...
FluoroPharma to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
13 janv. 2012 10h54 HE
|
FluoroPharma Medical, Inc.
BOSTON, Jan. 13, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical (OTCBB:FPMI), a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products, today announced...